Selectively targets RPE while preserving photoreceptors
R:GEN is the only macular laser proven to deliver safe, efficacious and precise targeting of Retinal Pigment Epithelium (RPE) cells. The breakthrough Real-time Feedback combined with the proprietary Dual Dosimetry and Auto Ramp-up technologies ensures you will target the RPE cells while leaving the photoreceptors undamaged.
The R:GEN 527 nm laser with 1.7 μs pulse width provides ideal energy to selectively target the RPE cells while minimizing thermal damage.
R:GEN utilizes pioneering and proprietary technology to enhance clinical outcomes and safety.
R:GEN’s patented Dual Dosimetry Technology utilizes reflectomery (back-scattered light) and opto-acoustic signaling (thermoeleastic pressure waves) to precisely monitor the exact timing of RPE cell destruction. As a result, treatments even within the fovea become possible.
The proprietary Dual Dosimetry function works in tandem with automatic ramping of laser pulse energy. Incremental pulse energy ramping allow treatments to stop at the exact point of RPE cell destruction, and are therefore optimized for every patient and every treatment.
R:GEN selectively targets and causes mechanical disruption of RPE cells without damaging photoreceptors, resulting in the regeneration of new and healthy RPE cells. Rather than causing gross thermal damage to the neural retina, choroid, and photoreceptors, R:GEN triggers new cell growth and repair of function.